ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0680

Altered miRNA patterns of peripheral blood mononuclear cells show correlations with pulmonary manifestations of systemic sclerosis

Dóra Csige, Szilárd Póliska, János Rózsa, Dóra Tari, Szilvia Szamosi, Zoltán Szekanecz, Gabriella Szűcs and Levente Bodoki, University of Debrecen, Debrecen, Hungary

Meeting: ACR Convergence 2025

Keywords: Micro-RNA, Systemic sclerosis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, October 26, 2025

Title: (0671–0710) Systemic Sclerosis & Related Disorders – Clinical Poster I

Session Type: Poster Session A

Session Time: 10:30AM-12:30PM

Background/Purpose: Systemic sclerosis (SSc) is an autoimmune rheumatic and musculoskeletal disease (RMD) with a high mortality. Epigenetic factors, such as miRNAs might play an important role in the pathogenesis of SSc. In this cross-sectional study we assessed miRNA in SSc and associated miRNA expression with disease-related organ manifestations.

Methods: We investigated the miRNA profiles of 52 SSc patients (42 women and 10 men; mean age: 59.1 years (range: 33-76 years). Anticoagulated blood samples were taken from SSc patients, as well as age- and gender-matched healthy controls. Peripheral blood mononuclear cells (PBMC) were isolated on a Ficoll gradient, stored in TRIzol at -20°C until use. Total RNA was purified. Sequencing of miRNAs was performed using high-throughput, new generation (Illumina) sequencing, and an established miRNA library.

Results: Altogether 58 miRNAs showed significantly differential expression in SSc patients compared to controls. Among these miRNAs, 34 were significantly upregulated and 24 downregulated. Out of the differentially expressed miRNAs, 9 upregulated (let-7e-3p, miR-16-1-3p, miR-16-2-3p, miR-27a-5p, miR-34c-5p, miR-92a-1-5p, miR-130b-5p, miR-143-5p, miR-183-5p) and 8 downregulated miRNAs (miR-7-1-3p, miR-17-5p, miR-20a-5p, miR-30b-5p, miR-106a-5p, miR-151a-5p, miR-320b és miR-335-5p) had previously been described in the literature. Thus, the differential expression of further 41 (25 upregulated and 16 downregulated) miRNAs is a novel finding. When comparing SSc patients with (n=34) and without (n=18) interstitial lung disease (ILD)/pulmonary fibrosis, 4 miRNAs (miR-210-3p, miR-222-3p, miR-379-5p, miR-3935-5p) showed elevated, while 4 miRNAs (miR-125a-5p, miR-199b-5p, miR-941, miR-1226-3p) showed decreased expression levels in patients with SSc-ILD. Some of the differentially expressed miRNAs are associated with TGFβ signalling pathways.

Conclusion: SSc is associated with differential expression of several miRNAs. The up- or down-regulated expression of some miRNAs might be associated with SSc-ILD. Thus, miRNAs might have an important role in the molecular pathogenesis of SSc, as well as SSc-ILD and some of them might serve as therapeutic targets as well.


Disclosures: D. Csige: None; S. Póliska: None; J. Rózsa: None; D. Tari: None; S. Szamosi: None; Z. Szekanecz: AbbVie/Abbott, 1, 2, Bristol-Myers Squibb(BMS), 1, 2, Eli Lilly, 1, 2, Janssen, 1, 2, Novartis, 1, 2, Pfizer, 1, 2, Roche, 1, 2; G. Szűcs: Boehringer-Ingelheim, 1, 2; L. Bodoki: None.

To cite this abstract in AMA style:

Csige D, Póliska S, Rózsa J, Tari D, Szamosi S, Szekanecz Z, Szűcs G, Bodoki L. Altered miRNA patterns of peripheral blood mononuclear cells show correlations with pulmonary manifestations of systemic sclerosis [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/altered-mirna-patterns-of-peripheral-blood-mononuclear-cells-show-correlations-with-pulmonary-manifestations-of-systemic-sclerosis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/altered-mirna-patterns-of-peripheral-blood-mononuclear-cells-show-correlations-with-pulmonary-manifestations-of-systemic-sclerosis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology